These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1858831)

  • 1. A prospective evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable.
    Greenberger PA; Cranberg JA; Ganz MA; Hubler GL
    Am J Med; 1991 Jul; 91(1):67-73. PubMed ID: 1858831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline disposition in Korean patients with congestive heart failure.
    Jeong CS; Hwang SC; Jones DW; Ryu HS; Sohn K; Sands CD
    Ann Pharmacother; 1994 Mar; 28(3):396-401. PubMed ID: 8193433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.
    DuBois B; Louey S; Giraud GD; Cherala G; Jonker SS
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):226-33. PubMed ID: 25728792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinafloxacin-theophylline drug interaction.
    Matuschka PR; Vissing RS
    Ann Pharmacother; 1995 Apr; 29(4):378-80. PubMed ID: 7633015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid estimation of serum theophylline clearance in children with acute asthma.
    Wells TG; Kearns GL; Stillwell PC; Brown AL; Trang JM; McConnell RF; Kluza RB
    Ther Drug Monit; 1984; 6(4):402-7. PubMed ID: 6393463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of theophylline. III. Premarketing study for a once-daily administered preparation.
    Tanigawara Y; Komada F; Shimizu T; Iwakawa S; Iwai T; Maekawa H; Hori R; Okumura K
    Biol Pharm Bull; 1995 Nov; 18(11):1590-8. PubMed ID: 8593486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM; Hudson SA; Jefferson GC
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
    Kishimoto I; Tanigawara Y; Okumura K; Hori R
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1237-42. PubMed ID: 2703972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of intravenous theophylline dosage based on a single, nonsteady-state concentration: a clinical study of childhood status asthmaticus.
    Kurland G; Anderson DA; Mitsuoka JC; Marquardt ED
    Pediatrics; 1988 Dec; 82(6):880-3. PubMed ID: 3186378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ordering of serum theophylline concentrations.
    Gentry SM; Keith TD; McMillan DM; Goetter WE
    Am J Hosp Pharm; 1981 Dec; 38(12):1937-9. PubMed ID: 7325177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three theophylline dosing equations for use in infants up to one year of age.
    Hogue SL; Phelps SJ
    J Pediatr; 1993 Oct; 123(4):651-6. PubMed ID: 8192745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent kinetics of theophylline in adults with pulmonary diseases.
    Massey KL; Gotz VP; Russell WL
    Ther Drug Monit; 1984; 6(3):284-9. PubMed ID: 6506135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline toxicity: clinical features of 116 consecutive cases.
    Sessler CN
    Am J Med; 1990 Jun; 88(6):567-76. PubMed ID: 2189301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two methods for estimating theophylline clearance prior to achieving steady state.
    Anderson G; Koup J; Slaughter R; Edwards WD; Resman B; Hook E
    Ther Drug Monit; 1981; 3(4):325-32. PubMed ID: 7336469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.